Eton Pharmaceuticals (ETON) Gross Margin (2019 - 2026)
Eton Pharmaceuticals (ETON) posted Gross Margin of 61.56% for Q4 2025, up 76.0% sequentially from 34.97% in Q3 2025, and up 595.0% YoY from 8.86% in Q4 2024.
Eton Pharmaceuticals (ETON) Gross Margin (2019 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Gross Margin for 7 years, with the latest figure at 61.56% in Q4 2025.
- Quarterly Gross Margin rose 595.0% year-over-year to 61.56% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 53.46% (down 655.0% YoY) and the FY2025 annual result came in at 53.46%, down 655.0% from the prior year.
- Gross Margin grew to 61.56% in Q4 2025 per ETON's latest filing, from 34.97% in the prior quarter.
- Over five years, Gross Margin peaked at 94.33% in Q2 2021 and troughed at 12.18% in Q4 2023.
- A 5-year average of 61.78% and a median of 62.33% in 2023 frame the typical range for Gross Margin.
- The widest YoY moves for Gross Margin: up 13433 bps in 2021, down 720611 bps in 2021.
- Over 5 years, Gross Margin stood at 93.89% in 2021, then declined by 20 bps to 74.84% in 2022, then slumped by 84 bps to 12.18% in 2023, then jumped by 356 bps to 55.6% in 2024, then increased by 11 bps to 61.56% in 2025.
- According to Business Quant data, Gross Margin over the past three periods registered 61.56%, 34.97%, and 63.0% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Eton Pharmaceuticals | 1.68 Bn | 1.65 Bn | 25.41 Mn | 67.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 67.61% |
| Dec 31, 2025 | 61.56% |
| Sep 30, 2025 | 34.97% |
| Jun 30, 2025 | 63.00% |
| Mar 31, 2025 | 57.06% |
| Dec 31, 2024 | 55.60% |
| Sep 30, 2024 | 61.04% |
| Jun 30, 2024 | 62.00% |
| Mar 31, 2024 | 62.85% |
| Dec 31, 2023 | 12.18% |
| Sep 30, 2023 | 62.65% |
| Jun 30, 2023 | 80.70% |
| Mar 31, 2023 | 63.08% |
| Dec 31, 2022 | 74.84% |
| Sep 30, 2022 | 40.36% |
| Jun 30, 2022 | 92.26% |
| Mar 31, 2022 | 60.98% |
| Dec 31, 2021 | 93.89% |
| Sep 30, 2021 | 15.61% |
| Jun 30, 2021 | 94.33% |